Nexalin Technology (NXL) Accumulated Expenses (2021 - 2026)
Nexalin Technology has reported Accumulated Expenses over the past 5 years, most recently at $642754.0 for Q4 2025.
- For Q4 2025, Accumulated Expenses rose 64.49% year-over-year to $642754.0; the TTM value through Dec 2025 reached $642754.0, up 64.49%, while the annual FY2025 figure was $642754.0, 64.49% up from the prior year.
- Accumulated Expenses for Q4 2025 was $642754.0 at Nexalin Technology, up from $290031.0 in the prior quarter.
- Over five years, Accumulated Expenses peaked at $642754.0 in Q4 2025 and troughed at $124966.0 in Q2 2024.
- A 5-year average of $423599.2 and a median of $393342.0 in 2025 define the central range for Accumulated Expenses.
- Biggest five-year swings in Accumulated Expenses: plummeted 79.3% in 2024 and later skyrocketed 188.08% in 2025.
- Year by year, Accumulated Expenses stood at $611795.0 in 2021, then fell by 11.76% to $539822.0 in 2022, then plummeted by 51.6% to $261284.0 in 2023, then soared by 49.55% to $390745.0 in 2024, then soared by 64.49% to $642754.0 in 2025.
- Business Quant data shows Accumulated Expenses for NXL at $642754.0 in Q4 2025, $290031.0 in Q3 2025, and $360004.0 in Q2 2025.